Shalvata Mental Health Center, Hod Hasharon, Israel
9 March, 2009
A double-blind placebo-controlled clinical trial utilizing the Brainsway®'s Deep TMS device for the treatment of negative symptoms in 45 patients with schizophrenia has begun at the Shalvata Mental Health Center.
The trial began on March 2009, and is expected to be carried out over the course of 7 weeks in respect of each subject.
This trial is expected to serve as the basis for a broad multi-center trial.